Acadia Pharmaceuticals Inc.
ent_019e61a684312e74858b01a8aae1bc00
Disclosures
9
State AG · 8 jurisdictions
Multi-filing incidents
2
incidents joining 2+ filings here
Max affected reported
14,065
nationwide · State AG DE
Leak-site claims
0
none in sample
Identity resolution
- Canonical name
- Acadia Pharmaceuticals Inc.
- Normalized
- acadia pharmaceuticals— dedupe via name-norm; Microsoft / MSFT collapse to one row
- GLEIF LEI
- 529900O3044NO0PEA039
- SEC EDGAR CIK
- 0001070494
- Domain
- None on record
Disclosure history (9)newest first
- Vermont State AGas victim2024-12-04
Acadia Pharmaceuticals Inc. disclosed a data breach affecting its 'More to Parkinson’s' community. Due to an internal email misconfiguration, a recipient's registered name was sent to another member's email address. Only names were exposed; no medical records or other PII were accessed. The incident was discovered on November 4, 2024, and regulators were notified.
- California State AGas victim2024-12-04
Acadia Pharmaceuticals Inc. experienced a data incident involving the misdelivery of emails to members of its 'More to Parkinson’s' community. Due to an internal error, emails sent between October 24 and November 4, 2024, contained recipient names that did not match the email addresses they were sent to, potentially disclosing the name of one individual to another. Acadia became aware of the incident on November 4, 2024. No medical records or other identifiable information beyond names were disclosed.
- Delaware State AGas victim2024-12-04
Acadia Pharmaceuticals, Inc. reported a data breach to the Delaware Attorney General. The breach occurred on 2024-10-24. It was discovered on 2024-11-04. Notice was filed on 2024-12-04. 14,065 individuals affected in total. Information involved: health basic.
- Montana State AGas victim2024-12-04
Acadia Pharmaceuticals Inc. disclosed a data incident where an internal error caused emails regarding its 'More to Parkinson’s' community to be sent with the wrong recipient name. The incident, discovered on November 4, 2024, involved the misdelivery of registered names to unintended recipients. No medical records were accessed. The company notified state regulators and affected individuals.
- Oregon State AGas victim2024-12-04
Acadia Pharmaceuticals Inc. reported a data breach to the Oregon Attorney General. The breach was reported on 2024-12-04. 14,065 individuals were affected.
- Illinois State AGas victim2024-12-01
ACADIA PHARMACEUTICALS, INC filed a data-breach notice with the Illinois Attorney General in December 2024 (case 24-12-002). The register records the breach as discovered on October 29, 2024. Illinois does not publish the number of people affected — 815 ILCS 530/10 permits the Attorney General to publish only the entity name, the types of personal information and the date range.
- Indiana State AGas victim2024-05-21
Acadia Pharmaceuticals Inc reported a data breach to the Indiana Attorney General. The breach occurred on 2024-02-21 and was reported on 2024-05-21. 873 Indiana residents were affected.
- Washington State AGas victim2024-05-21
The Lash Group, a third-party service provider for Acadia Pharmaceuticals, disclosed a cyberattack in May 2024. Data exfiltrated from Lash Group's systems included patient PII (names, addresses, DOB) and PHI (health diagnoses, medications). The incident was discovered on Feb 21, 2024. 851 Washington residents were affected. Lash Group engaged forensic experts and offered 24 months of credit monitoring.
- Montana State AGas reporting2024-05-20
Cencora, Inc. notified Montana residents that on February 21, 2024, data from its information systems was exfiltrated. The incident involved personal information (name, address, DOB) and health information (diagnosis, medications) of individuals in patient support programs. Cencora engaged law enforcement and cybersecurity experts, contained the incident, and offered 24 months of credit monitoring.